Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al

Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al

Bibliografiset tiedot
Päätekijät:	Campbell, P, Bareford, D, Erber, W, Wilkins, B, Wright, P, Buck, G, Wheatley, K, Harrison, C, Green, A
Aineistotyyppi:	Journal article
Julkaistu:	2009

Samankaltaisia teoksia

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
Tekijä: Wilkins, B, et al.
Julkaistu: (2008)

Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
Tekijä: Campbell, P, et al.
Julkaistu: (2009)

Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
Tekijä: Beer, P, et al.
Julkaistu: (2007)

The medical research council PT1 trial in essential thrombocythemia.
Tekijä: Green, A, et al.
Julkaistu: (2004)

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Tekijä: Harrison, C, et al.
Julkaistu: (2005)

Classification of Philadelphia Translocation-Negative Myeloproliferative Neoplasms: Its Impact on Data From Clinical Trials Reply
Tekijä: Campbell, P, et al.
Julkaistu: (2009)

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
Tekijä: Green, A, et al.
Julkaistu: (2005)

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort.
Tekijä: Campbell, P, et al.
Julkaistu: (2012)

Myelofibrotic transformation in essential thrombocythemia. Author reply
Tekijä: Francesco Passamonti, et al.
Julkaistu: (2009-03-01)

DEREGULATION OF BONE MARROW EICOSANOIDS IN ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS PATIENTS
Tekijä: J.G. Cominal, et al.
Julkaistu: (2020-11-01)

Bibliografie dr. P. J. J. van Thiel
Julkaistu: (1991-12-01)

Emerging treatments for essential thrombocythemia
Tekijä: Okoli S, et al.
Julkaistu: (2011-12-01)

Essential Thrombocythemia
Tekijä: Kanchanee Janwanitsthaporn
Julkaistu: (2002-08-01)

Essential thrombocythemia
Tekijä: Brière Jean B
Julkaistu: (2007-01-01)

Ruxolitinib for the Treatment of Essential Thrombocythemia
Tekijä: Arief Gunawan, et al.
Julkaistu: (2018-08-01)

Bij het afscheid van dr. P. J. J. van Thiel
Tekijä: H. W. van Os
Julkaistu: (1991-12-01)

Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations
Tekijä: Samah Alimam, et al.
Julkaistu: (2018-06-01)

Assessing Bone Marrow Activity with []FLT PET in Patients with Essential Thrombocythemia and Prefibrotic Myelofibrosis: A Proof of Concept
Tekijä: Mohamed A. Yassin MBBS, CABM, MSC, FACP, MSC, et al.
Julkaistu: (2022-03-01)

Neuromyotonia in association with essential thrombocythemia.
Tekijä: Benito-León, J, et al.
Julkaistu: (2000)

Neurological disorders in essential thrombocythemia
Tekijä: Segolene Billot, et al.
Julkaistu: (2011-12-01)

Myelofibrotic transformation in essential thrombocythemia
Tekijä: Juergen Thiele, et al.
Julkaistu: (2009-03-01)

Mutations and thrombosis in essential thrombocythemia
Tekijä: Paola Guglielmelli, et al.
Julkaistu: (2021-04-01)

Thromboembolic complication in Essential Thrombocythemia
Tekijä: Zahra Mozaheb
Julkaistu: (2012-11-01)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
Tekijä: Beer, P, et al.
Julkaistu: (2008)

Generalized granuloma annulare associated with essential thrombocythemia
Tekijä: Sai P. Polineni, et al.
Julkaistu: (2020-06-01)

Essential thrombocythemia associated with fibrosis involving bilateral renal sinuses: A case report
Tekijä: Adeleh Dadkhah, MD, et al.
Julkaistu: (2023-10-01)

The Levels of Adhesion Molecules in Essential Thrombocythemia
Tekijä: Oktay Bilgir, et al.
Julkaistu: (2014-08-01)

Moyamoya syndrome in an adult with essential thrombocythemia
Tekijä: Marc Lazzaro, et al.
Julkaistu: (2011-04-01)

Acute thrombotic complication of essential thrombocythemia
Tekijä: Selami Koçak Toprak, et al.
Julkaistu: (2011-12-01)

Essential thrombocythemia: Rare cause of chorea
Tekijä: Eswaradass Prasanna Venkatesan, et al.
Julkaistu: (2014-01-01)

Essential thrombocythemia presenting as digital ischemia
Tekijä: Md. Nazmul Hasan, et al.
Julkaistu: (2017-09-01)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
Tekijä: Campbell, P, et al.
Julkaistu: (2005)

ARACHIDONIC ACID (AA)-DERIVED LIPID MEDIATORS ARE INCREASED IN THE BONE MARROW PLASMA FROM POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS
Tekijä: M.C. Cacemiro, et al.
Julkaistu: (2020-11-01)

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply
Tekijä: Thomas Buhr, et al.
Julkaistu: (2012-03-01)

Retinal neovascularization in the setting of -mutation positive essential thrombocythemia
Tekijä: Stanton P Heydinger, et al.
Julkaistu: (2023-08-01)

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
Tekijä: A. A. Zhernyakova, et al.
Julkaistu: (2017-06-01)

“Y appearance” infarction: caused by essential thrombocythemia
Tekijä: Shuyue Xiao, et al.
Julkaistu: (2024-10-01)

Multilevel defects in the hematopoietic niche in essential thrombocythemia
Tekijä: Ting Sun, et al.
Julkaistu: (2020-03-01)

Prevention of thrombosis in polycythemia vera and essential thrombocythemia
Tekijä: Raffaele Landolfi, et al.
Julkaistu: (2008-03-01)

Essential thrombocythemia manifesting as ophthalmic artery occlusion
Tekijä: Kittipong Thabsuwan, et al.
Julkaistu: (2020-06-01)